| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99241 |
|
5,292 |
3,565 |
$513K |
| 99242 |
|
1,417 |
1,133 |
$209K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
1,149 |
1,118 |
$128K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,167 |
1,386 |
$61K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,172 |
1,552 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,439 |
2,254 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,635 |
1,110 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,346 |
1,465 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,967 |
1,999 |
$4K |
| S9083 |
Global fee urgent care centers |
162 |
144 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
671 |
479 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
575 |
415 |
$881.51 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
697 |
378 |
$398.36 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
261 |
153 |
$187.81 |
| 81003 |
|
649 |
429 |
$71.94 |
| 94760 |
|
414 |
251 |
$52.80 |
| 87807 |
|
46 |
45 |
$50.30 |
| 81025 |
|
21 |
12 |
$5.17 |
| 99201 |
|
16 |
15 |
$0.00 |